Viewing Study NCT02095834


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-03-11 @ 5:34 PM
Study NCT ID: NCT02095834
Status: COMPLETED
Last Update Posted: 2021-01-11
First Post: 2014-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Plasma Cell Myeloma View
None Refractory Plasma Cell Myeloma View
Keywords: